CURI vs MPU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

CURI

37.6
AI Score
VS
MPU Wins

MPU

42.2
AI Score

Investment Advisor Scores

CURI

38score
Recommendation
SELL

MPU

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI MPU Winner
Forward P/E 22.8833 3.9463 MPU
PEG Ratio 0 0 Tie
Revenue Growth 0.5% -49.2% CURI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.6/100 42.2/100 MPU
Profit Margin -11.3% -131.4% CURI
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD MPU

Relative Price Performance (Last 90 Days)

CURI 1M: -13.1% · 3M: -20.2% MPU 1M: -21.4% · 3M: -54.1%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.8 · Price: $2.53

MPU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -29.5%), weak momentum, RSI 42

RSI (14): 41.6 · Price: $0.24

Fundamentals Snapshot

Metric CURI MPU
Market Cap
Forward P/E 10.5 3.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.5%
Gross Margin 0.6% 0.6%
Operating Margin -0.1% -3.8%
EPS -0.14 -0.75
Dividend Yield 0.13%

Frequently Asked Questions

Based on our detailed analysis, MPU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.